---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-071354"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:18:52.197620+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Crinetics shareholders re-elect directors, ratify auditor, approve NEO pay

## Summary
- Dr. Camille Bedrosian elected with 50.8M votes for (77%), 14.9M withheld; Dr. Wendell Wierenga with 50.3M for (76%).
- Ratified BDO USA as independent auditor for FY 2024: 68.0M for, 0.1M against, 16.0K abstain.
- Advisory vote on named executive officer compensation approved: 64.1M for, 1.7M against, 6.0K abstain, 2.3M broker non-votes.
- Approximately 78.7M shares (86% of eligible) voted at the June 7, 2024 annual meeting.

## SEC filing metadata
- accession: 0000950170-24-071354
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000095017024071354/0000950170-24-071354-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000095017024071354/crnx-20240607.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-071354
- JSON: https://secwatch.observer/filing/0000950170-24-071354.json
- Plain text: https://secwatch.observer/filing/0000950170-24-071354.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.